Zimmer, Tutogen give international extension to graft pact:
This article was originally published in Clinica
Executive Summary
Zimmer Dental and biological implant specialist Tutogen Medical have extended a partnership to distribute the latter's Puros bone grafting products in Europe, the Middle East and Asia. Zimmer currently distributes the brand in the US, Canada and Latin America, and will be hoping to reinforce its position in a worldwide market that is valued at around $300m per year, according to Alachua, Florida-based Tutogen. The agreement relates to human- and animal-derived bone grafts used to enhance the mandible and maxilla. The grafts are manufactured using the patented Tutoplast process of removing unwanted fats, cells, antigens, and inactivates pathogens, while preserving valuable minerals and collagen matrix that lead to rapid bone regeneration.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.